Ex-Roche Executive Mahler On Past, Present And Future Of Swiss CDMOs
With ten years of experience at Roche under his belt, ten23 CEO and co-founder talked to Scrip about trends in the Swiss manufacturing landscape, from pandemic-related capacity growth to increased demand for small-batch production and sustainability efforts.
